Vinnova

BeammWave AB, founded in 2016 and based in Lund, Sweden, specializes in the development of radio frequency integrated chips that facilitate digital beamforming. The company's innovative technology includes a single chip integrating front-end components and antenna arrays specifically designed for mobile phones and Internet of Things (IoT) devices operating in the millimeter-wave spectrum. This technology is particularly relevant for applications in 5G and future communication systems, enabling enhanced connectivity and performance in a variety of devices.

Saab Ventures, established in 2001, is the corporate venture capital arm of Saab AB, headquartered in Stockholm, Sweden. It invests in technology companies, with a focus on those rooted in the defense, civil security, aviation, and space sectors. The firm makes both direct investments in startups and early-stage companies, as well as fund-of-fund investments in venture capital funds. Saab Ventures typically invests between SEK0.1 million and SEK50 million, seeking companies with an enterprise value between SEK40 million and SEK100 million within five years, and existing or potential revenues of SEK100 million within the same period. It prefers minority equity positions and co-investment opportunities, with an investment horizon of four to seven years.

XNK Therapeutics is a clinical-stage biotechnology company based in Stockholm, Sweden, specializing in immunotherapy for cancer prevention and treatment. The company develops innovative therapies centered on autologous natural killer (NK) cells utilizing its proprietary technology platform. This platform enables the creation of NK cell-based products that are particularly effective in targeting cancers, especially in scenarios where allogeneic cell therapies may not be suitable. XNK Therapeutics aims to play a pivotal role in advancing cancer treatment strategies through its leading investigational drug candidates and established expertise in the development and manufacture of these specialized therapies.

Qlucore is a prominent provider of innovative bioinformatics software designed for research and precision diagnostics, focusing on the analysis of complex data generated in genetics and proteomics. The company offers two main products: Qlucore Omics Explorer, a user-friendly bioinformatics tool for researchers in life sciences, biotechnology, and academia, and Qlucore Diagnostics, a platform aimed at companion and precision diagnostics that incorporates AI-powered machine learning classifiers and patient-friendly visualizations. Founded in 2007 by researchers from Lund University in Sweden, Qlucore aims to simplify the interpretation of large datasets, enabling researchers, technicians, and physicians to derive insights efficiently. With a presence in approximately 35 countries and a customer base that includes leading pharmaceutical companies, hospitals, and universities, Qlucore is committed to enhancing data analysis capabilities in the life sciences sector.

Intervacc is a biotechnology company that specializes in developing vaccines based on recombinant proteins for animal health care. The company addresses the growing demand for effective vaccines and also emphasizes diagnostics within the animal health sector. Through its subsidiary, Intervacc provides bacteriological and mycological analyses specifically in the Swedish market.

Mycorena AB, founded in 2017 and based in Gothenburg, Sweden, specializes in developing nutritious fungi-based protein as a sustainable alternative to both meat and traditional plant-based proteins. The company leverages fungi biotechnology to create vegan protein products that require significantly fewer resources than conventional food production methods. By focusing on sustainability and resource efficiency, Mycorena aims to address global sustainability challenges and promote a circular economy. Its innovative solutions contribute to a more environmentally friendly food industry, enabling customers to make choices that positively impact the planet.

InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.

Jaisy Health is a company based in Stockholm, Sweden, that specializes in developing jaundice detection equipment aimed at providing a low-cost and highly accurate solution for non-invasive jaundice assessment in infants. Founded in 2018, Jaisy Health utilizes advanced technology to create an optical mobile device that connects to smartphones. This device measures bilirubin levels and predicts the risk of jaundice, enabling timely and accessible detection regardless of location or time. By focusing on affordability and accuracy, Jaisy Health offers an innovative approach to managing jaundice in newborns.

Redsense Medical AB develops and markets advanced safety systems for medical treatments, focusing primarily on the dialysis sector in Europe and the United States. The company's flagship product, the Redsense System, utilizes patented fiber optic sensors to detect blood leakage during hemodialysis, triggering visual and audible alarms to alert caregivers and ensuring prompt response to potential issues. This system also monitors venous needle dislodgement at the blood access site. Additionally, Redsense Medical is working on the Redsense Clamp, an accessory designed to automatically stop blood flow by clamping the blood line in the event of a leak. Founded in 2000 and headquartered in Halmstad, Sweden, Redsense Medical aims to enhance patient safety and care in dialysis treatment through innovative technology.

Mendi is a company based in Stockholm, Sweden, established in 2018, that specializes in developing an at-home Neurofeedback Brain Training headband paired with a mobile application. This innovative device aims to enhance mental well-being by helping users improve focus, regulate emotions, and build mental resilience. The headband provides a user-friendly experience, allowing individuals to engage in unlimited mental training sessions, thereby promoting better mental health and performance. Mendi's approach combines hardware and software to create a comprehensive solution for individuals seeking to strengthen their cognitive abilities and overall mental health.

Yolean AB is a company based in Gothenburg, Sweden, that specializes in developing visual management tools aimed at facilitating digital Lean transformation. The company provides software that integrates wall-based visual management techniques with backend data management, enabling project line and knowledge managers, as well as Lean transformation leaders, to enhance visibility and transparency in knowledge work. Yolean's software allows for real-time interaction across multiple screens, facilitating collaboration among team members from various locations or organizations. Additionally, it helps identify and quantify bottlenecks in workflows. The company's product offerings include visual planning tools, pulse solutions, and check sheets, serving clients primarily in the automotive and public sectors. Through its focus on Lean visual management and knowledge management, Yolean aims to support businesses in achieving continuous, data-driven improvements in their project management processes.

TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.

Grönska is a young, Swedish tech-company that develops technology for vertical farming, and grows and sells vegetables and herbs. Vertical farming that is based on the use of LED lighting and hydroponic watering systems. This method allows us to grow food indoors, locally and all year round. The reason we do this is to offer a sustainable, locally grown alternative to imported food and to enable more self-sufficient cities. Grönska was founded in 2014 and constructed the largest vertical farm in the Nordics in 2018.

Bintel AB is a Swedish company founded in 2018, specializing in the development and marketing of innovative sensors for waste management. Their primary product is a digital waste-management platform that includes sensors mounted on household waste bins, which notify waste collectors when containers are full. This technology enhances the efficiency of waste collection by directly communicating with route planning tools used by waste trucks, helping municipalities, recycling companies, and real estate businesses optimize their collection routes and reduce operational costs. Based in Helsingborg, Bintel aims to improve waste management practices through its advanced sensor technology.

DeviceRadio AB, founded in 2016 and based in Malmö, Sweden, specializes in developing a communication layer that facilitates data transfer across various devices and connectivity methods within the Internet of Things (IoT) ecosystem. The company's innovative solution allows seamless communication regardless of the connection type, including Bluetooth, cellular networks, WiFi, and SMS. DeviceRadio addresses the complexity and fragmentation in the IoT landscape by providing a common infrastructure that enables diverse devices to communicate effectively. This initiative not only simplifies the development process for thousands of developers but also aims to enhance the potential applications of IoT, such as improving emergency response times and agricultural efficiency. Through its efforts, DeviceRadio strives to create a more integrated and cohesive environment for IoT advancements.

Spago Nanomedical AB is a Swedish company engaged in the research and development of nanomaterials for cancer diagnosis and treatment. Founded in 2007 and based in Lund, the company specializes in innovative products designed to enhance cancer care. Its flagship offerings include SpagoPix, a tumor-selective contrast agent aimed at improving cancer diagnosis through magnetic resonance imaging, and Tumorad, a novel radionuclide therapy that delivers targeted radiation to tumor tissues. The development of these products is grounded in a platform of polymeric materials, which enables precise diagnosis and treatment of life-threatening diseases. Spago Nanomedical's advancements hold promise for more effective cancer therapies, focusing on both early detection and targeted treatment options.

Imagimob AB, based in Stockholm, Sweden, specializes in developing artificial intelligence products focused on movement analytics for both people and objects. The company's flagship offering, SensorBeat, is a comprehensive motion intelligence system that integrates hardware and software components, including sensors, firmware, and artificial intelligence capabilities. This technology enables real-time AI processing on edge devices, facilitating applications such as audio classification, gesture recognition, predictive maintenance, and fall detection. By providing a robust platform, Imagimob allows companies to efficiently create and deploy AI applications tailored for embedded devices, enhancing their operational capabilities and performance.

TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.

DeviceRadio AB, founded in 2016 and based in Malmö, Sweden, specializes in developing a communication layer that facilitates data transfer across various devices and connectivity methods within the Internet of Things (IoT) ecosystem. The company's innovative solution allows seamless communication regardless of the connection type, including Bluetooth, cellular networks, WiFi, and SMS. DeviceRadio addresses the complexity and fragmentation in the IoT landscape by providing a common infrastructure that enables diverse devices to communicate effectively. This initiative not only simplifies the development process for thousands of developers but also aims to enhance the potential applications of IoT, such as improving emergency response times and agricultural efficiency. Through its efforts, DeviceRadio strives to create a more integrated and cohesive environment for IoT advancements.

Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.

Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

Fundler AB is a Swedish company that provides a digital platform for private investors to manage their savings portfolios automatically. Founded in 2015 and based in Stockholm, the company operates as a robo-adviser, offering a tailored model of funds and exchange-traded funds that align with each customer's investment horizon, financial situation, risk profile, goals, knowledge, and experience. Fundler's platform facilitates the automation of investment management, allowing users to receive financial advice, access investment information, and execute buy or sell orders directly through the app. By combining low-cost index funds with optimized risk strategies, Fundler enables users to invest according to their individual requirements, thereby enhancing their ability to grow savings effectively.

Bokio AB, founded in 2015 and based in Gothenburg, Sweden, specializes in developing and marketing accounting software that leverages artificial intelligence. The company provides solutions for bookkeeping, invoicing, and payroll services, making accounting accessible to small business owners, particularly in the UK. Its platform automates various financial processes, allowing users to efficiently manage their finances in one place. Additionally, Bokio serves as a marketplace for supplementary services that assist small business owners in simplifying their operations, including finding optimal insurance and pension solutions. The company also collaborates with partners to offer services like invoice sales to enhance liquidity and facilitates the sending of payslips and invoices through conventional mail, encompassing printing, envelopes, and postage.